These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29653556)

  • 1. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
    Banas T; Pitynski K; Okon K; Winiarska A
    BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial Polyps and Benign Endometrial Hyperplasia Have Increased Prevalence of DNA Fragmentation Factors 40 and 45 (DFF40 and DFF45) Together With the Antiapoptotic B-Cell Lymphoma (Bcl-2) Protein Compared With Normal Human Endometria.
    Banas T; Pitynski K; Mikos M; Cielecka-Kuszyk J
    Int J Gynecol Pathol; 2018 Sep; 37(5):431-440. PubMed ID: 28914671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival.
    Banas T; Pitynski K; Okon K; Czerw A
    Onco Targets Ther; 2017; 10():4579-4589. PubMed ID: 29075126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoexpression of DNA fragmentation factor 40, DNA fragmentation factor 45, and B-cell lymphoma 2 protein in normal human endometrium and uterine myometrium depends on menstrual cycle phase and menopausal status.
    Banas T; Pitynski K; Okon K; Mikos M; Czerw AI; Deptała A; Ludwin A
    Arch Med Sci; 2018 Oct; 14(6):1254-1262. PubMed ID: 30393479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
    Gu J; Dong RP; Zhang C; McLaughlin DF; Wu MX; Schlossman SF
    J Biol Chem; 1999 Jul; 274(30):20759-62. PubMed ID: 10409614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.
    Sanci M; Güngördük K; Gülseren V; Karadeniz T; Kocaer M; Gungorduk O; Özdemir İA
    Int J Gynecol Pathol; 2018 Jan; 37(1):17-21. PubMed ID: 28319574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of DFF40 and DFF45 N-terminal domain complex and mutual chaperone activity of DFF40 and DFF45.
    Zhou P; Lugovskoy AA; McCarty JS; Li P; Wagner G
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6051-5. PubMed ID: 11371636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DFF45 expression in ovarian endometriomas.
    Banas T; Skotniczny K; Basta A
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):87-91. PubMed ID: 19535198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H
    Pathol Res Pract; 2007; 203(2):65-72. PubMed ID: 17258405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DFF45 expression in human endometrium is associated with menstrual cycle phases and decreases after menopause.
    Banas T; Basta P; Knafel A; Skotniczny K; Jach R; Hajdyla-Banas I; Grabowska O
    Gynecol Obstet Invest; 2012; 73(3):177-82. PubMed ID: 22378161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of DFF45 in its role of chaperone and inhibitor: two independent inhibitory domains of DFF40 nuclease activity.
    McCarty JS; Toh SY; Li P
    Biochem Biophys Res Commun; 1999 Oct; 264(1):176-80. PubMed ID: 10527860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
    Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
    Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
    Fadare O; Parkash V
    Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing.
    Van Gool IC; Ubachs JEH; Stelloo E; de Kroon CD; Goeman JJ; Smit VTHBM; Creutzberg CL; Bosse T
    Histopathology; 2018 Jan; 72(2):248-258. PubMed ID: 28795426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of endometrial cancer patients with positive lymph nodes.
    Brown AP; Gaffney DK; Dodson MK; Soisson AP; Belnap TW; Alleman K; Sause WT
    Int J Gynecol Cancer; 2013 Jun; 23(5):861-8. PubMed ID: 23598890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
    Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
    J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional and temporal alterations in DNA fragmentation factor (DFF)-like proteins following experimental brain trauma in the rat.
    Zhang C; Raghupathi R; Saatman KE; LaPlaca MC; McIntosh TK
    J Neurochem; 1999 Oct; 73(4):1650-9. PubMed ID: 10501212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
    Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
    Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis.
    Casanova J; Duarte GS; da Costa AG; Catarino A; Nave M; Antunes T; Serra SS; Dias SS; Abu-Rustum N; Lima J
    Gynecol Oncol; 2024 Mar; 182():99-107. PubMed ID: 38262245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.